Effect of Intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL)

2017 ◽  
Vol 92 ◽  
pp. 1095-1102 ◽  
Author(s):  
Majid Ahmadi ◽  
Samaneh Abdolmohammadi-vahid ◽  
Mahnaz Ghaebi ◽  
Leili Aghebati-Maleki ◽  
Amir Afkham ◽  
...  
Keyword(s):  
Intravenous Immunoglobulin ◽  
Pregnancy Outcome ◽  
Pregnancy Loss ◽  
Recurrent Pregnancy Loss ◽  
Th1 And Th2 Lymphocytes ◽  
Th1 And Th2

Intravenous immunoglobulin for women with recurrent pregnancy loss and elevated NK cell cytotoxicity

2012 ◽  
Vol 94 (1) ◽  
pp. 41-42
Author(s):  
A. Fukui ◽  
A. Funamizu ◽  
M. Yokota ◽  
M. Kamoi ◽  
R. Fukuhara ◽  
...  
Keyword(s):  
Intravenous Immunoglobulin ◽  
Pregnancy Loss ◽  
Recurrent Pregnancy Loss ◽  
Nk Cell ◽  
Cell Cytotoxicity ◽  
Nk Cell Cytotoxicity

scholarly journals Treatment with intravenous immunoglobulin increases the level of small EVs in plasma of pregnant women with recurrent pregnancy loss

2020 ◽  
Vol 140 ◽  
pp. 103128
Author(s):  
Malene Møller Jørgensen ◽  
Rikke Bæk ◽  
Jenni Sloth ◽  
Kim Varming ◽  
Ole Bjarne Christiansen ◽  
...  
Keyword(s):  
Pregnant Women ◽  
Intravenous Immunoglobulin ◽  
Pregnancy Loss ◽  
Recurrent Pregnancy Loss

scholarly journals When conventional treatment fails: the role of intravenous immunoglobulin in recurrent pregnancy loss secondary to antiphospholipid syndrome

2013 ◽  
Vol 6 (2) ◽  
pp. 76-79 ◽  
Author(s):  
Jacklyn Chay ◽  
Karin Lust ◽  
Paul Kubler ◽  
Leonie Callaway
Keyword(s):  
Intravenous Immunoglobulin ◽  
Antiphospholipid Syndrome ◽  
Conventional Therapy ◽  
Pregnancy Loss ◽  
Recurrent Pregnancy Loss ◽  
Immunoglobulin Therapy ◽  
Intravenous Immunoglobulin Therapy ◽  
First Line Therapy ◽  
Low Dose Aspirin

Recurrent pregnancy loss (RPL) is a well-recognized complication of antiphospholipid syndrome (APS). First line therapy consists of low dose aspirin and heparin. Despite conventional therapy some women fail to achieve a successful pregnancy outcome. We describe the case of a patient who had two live births following intravenous immunoglobulin therapy despite previous failure with conventional therapy for RPL in the setting of APS. We will summarize the available literature on intravenous immunoglobulin for this indication.

Treatment with intravenous immunoglobulin in patients with recurrent pregnancy loss: An update

2019 ◽  
Vol 133 ◽  
pp. 37-42 ◽  
Author(s):  
Ole B. Christiansen ◽  
Astrid M. Kolte ◽  
Maria C. Krog ◽  
Henriette S. Nielsen ◽  
Pia Egerup
Keyword(s):  
Intravenous Immunoglobulin ◽  
Pregnancy Loss ◽  
Recurrent Pregnancy Loss

scholarly journals Intravenous Immunoglobulin Suppresses Abortion Relates to an Increase in the CD44bright NK Subset in Recurrent Pregnancy Loss Model Mice

2016 ◽  
Vol 95 (2) ◽  
pp. 37-37 ◽  
Author(s):  
J. Tanaka ◽  
A. Kitashoji ◽  
Y. Fukunaga ◽  
J. Kashihara ◽  
A. Nakano ◽  
...  
Keyword(s):  
Intravenous Immunoglobulin ◽  
Pregnancy Loss ◽  
Recurrent Pregnancy Loss ◽  
Loss Model
Sign in / Sign up

Export Citation Format

Share Document